1Bodey GP,De Jongh D,Isassi A,et al.Hypersplenism due to disseminated candidiasis in a patient with acute leukemia[J].Cancer,1969,24(2):417 -420.
2Massod A,Sallah S.Chronic disseminated candidiasis in patients with acute leukemia:emphasis on diagnostic definition and treatment[J].Leuk Res,2005,29 (5):493-501.
3Grois N,Mostbeck G,Scherrer R,et al.Hepatic and splenic abscesses,a common complication of intensive chemotherapy of acute myeloid leukemia[J].Ann Hematol,1991,63 (1):33-38.
4Sallah S,Senelka RC,Wehbick,et al.Hepatosplenie candidiasis in patients with acute leukemia[J].Br J Haematol,1999,106:697 -701.
5Pestalozzi BC,Krestin GP,Schanz U,et al.Hepatic lesions of chronic disseminated candidiasis may become invisible during neutropenia[J].Blood,1997,90 (10):3858-3864.
6Rossetti F,Braowner DL,Bowden R,et al.Fungal liver infections in marrow transplant recipients,prevalence at autopsy,predisposing facters and clinical features[J].Clin Infect Dis,1995,20:801 -811.
8Pagano L,Mele L,Fianchi L,et al.Chronic disseminated candidiasis in patients with hematologic malignancies,clinical features and outcome of 29 episodes[J].Haematologica,2002,87:535-541.
9Pappas PG,Rex JH,Sobel JD,et al.Guidelines for treatment of candidiasis[J].Clin Infect Dis,2004,38 (2):161-189.
7Herbrecht R,Denning DW,Patterson TF,et al.Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.N EnglJ Med,2002,347:408-415.
8Pfaller MA,Messer SA,Hollis RJ,et al.Antifungal activities of posaconazole,ravuconazole,and voriconazole compared to those of itraconazole and amphotericin B,against 239 clinical isolates of asppergillus spp,and other Filamentous fungi:report from SENTRY antimicrobial surveillance program,2000[J].Antimicrob Agents Chemotherapy,2002,46 (4):1032 -1037.
9Kauffman CA,Carrer PL.Antifungal angents in the 1990s.Current status and future developments[J].Drugs,1997,53(4):539 -549.
10Caillot D,Bassaris H,McGeer A,et al.Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergllosis in patients with hematologic malignancies,chronic granulomatous distrase,or AIDS[J].Clin Infect Dis,2001,33 (8):83-90.
3Bodey GP, DeJongh D, Isassi A, et al. Hypersplenism due to disseminated candidiasis in a patient with acute leukemia [J]. Cancer, 1969, 24 (2) :417-420.
4Grois N, Mostbeck G, Scherrer R, et al. Hepatic and splenic abscesses--a common complication of intensive chemotherapy of acute myeloid leukemia (AML). A prospective study [J]. Ann Hematol, 1991, 63( 1 ):33-38.
5Pestalozzi BC, Krestin GP, Schanz U, et al. Hepatic lesions of chronic disseminated candidiasis may become invisible during neutropenia[J]. Blood, 1997, 90(10) :3858-3864.
6Sallah S,Wan JY, Nguyen NP, et al. Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non-bone marrow transplant setting: a follow-up study[J]. Cancer, 2001,92(6):1349-1353.
7Borg-yon Zepelin M, Kunz L, Rfiehel R, et al. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fimgaemia in Germa- ny from July 2004 to August 2005 [J]. J Antimicrob Chemother, 2007, 60(2) :424-428.
8Haron E, Feld R, Tuffnell P, et al. Hepatic candidiasis: an increasing problem in immunocompromised patients [J]. Am J Med, 1987, 83 ( 1 ): 17-26.
9Sallah S, Semelka RC, Wehbie R, et al. Hepatosplenic candidia- sis in patients with acute leukaemia [J]. Br J Haematol, 1999, 106(3):697-701.
10Roilides E, Sein T, Schaufele R, et al. Increased serum concentra- tions of interleukin- 10 in patients with hepatosplenic candidiasis [J]. J Infect Dis,1998,178(2):589-592.
